Alnylam Pharmaceuticals, Inc.

Direct answer

Alnylam Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ALNY.

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company primarily dedicated to the discovery, development, and commercialization of innovative therapeutic solutions leveraging ribonucleic acid interference (RNAi) technology. Its robust pipeline of RNAi-based treatments addresses a range of critical therapeutic areas, including inherited genetic disorders, cardio-metabolic conditions, hepatic infectious...

Can you invest in Alnylam Pharmaceuticals, Inc.?

Yes. Alnylam Pharmaceuticals, Inc. trades publicly on NASDAQ as ALNY.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Alnylam Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.